Molecular pathogenesis and heterogeneity in type 3 VWD families in U.S. Zimmerman program von Christopherson, Pamela A., Haberichter, Sandra L., Flood, Veronica H., Perry, Crystal L., Sadler, Brooke E., Bellissimo, Daniel B., Di Paola, Jorge, Montgomery, Robert R., Abshire, T, Weiler, H, Lillicrap, D, James, P, O’Donnell, J, Ng, C, Bennett, C, Sidonio, R, Manco‐Johnson, M, Journeycake, J, Zia, A, Lusher, J, Rajpurkar, M, Shapiro, A, Lentz, S, Gill, J, Leissinger, C, Ragni, M, Tarantino, M, Roberts, J, Hord, J, Strouse, J, Ma, A, Valentino, L, Boggio, L, Sharathkumar, A, Gruppo, R, Kerlin, B, Kulkarni, R, Green, D, Hoots, K, Brown, D, Mahoney, D, Mathias, L, Bedros, A, Diamond, C, Neff, A, DiMichele, D, Giardina, P, Cohen, A, Paidas, M, Werner, E, Matsunaga, A, Shafer, F, Konkle, B, Cuker, A, Kouides, P, Stein, D

Volltext

Subcutaneous diphtheria and tetanus vaccines in children with haemophilia: A pilot study and review of the literature von Schaefer, B. A., Gruppo, R. A., Mullins, E. S., Tarango, C.

Volltext

Efficacy and safety of pegylated full-length recombinant factor VIII with extended half-life for perioperative haemostasis in haemophilia A patients von Brand, B., Gruppo, R., Wynn, T. T., Griskevicius, L., Lopez Fernandez, M. F., Chapman, M., Dvorak, T., Pavlova, B. G., Abbuehl, B. E.

Volltext

The use of a single von Willebrand factor‐containing, plasma‐derived FVIII product in hemophilia A immune tolerance induction: the US experience von KURTH, M., PUETZ, J., KOUIDES, P., SANDERS, J., SEXAUER, C., BERNSTEIN, J., GRUPPO, R., MANCO‐JOHNSON, M., NEUFELD, E. J., RODRIGUEZ, N., WICKLUND, B., QUON, D., ALEDORT, L.

Volltext

Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin-free method: pharmacokinetics, efficacy, and safety in previously treated patient... von Tarantino, M. D., Collins, P. W., Hay, C. R. M., Shapiro, A.D., Gruppo, R. A., Berntorp, E., Bray, G. L., Tonetta, S. A., Schroth, P. C., Retzios, A. D., Rogy, S. S., Sensel, M. G., Ewenstein, B. M.

Volltext

Radionuclide synovectomy/synoviorthesis (RS) in persons with bleeding disorders: A review of impact of national guidance on frequency of RS using the ATHNdataset von Sharma, R., Dunn, A., Aschman, D., Cheng, D., Wheeler, A., Soni, A., McGuinn, C., Knoll, C., Stein, D. T., Young, G., French, J., Sanders, J., Davis, J. A., Tarantino, M., Lim, M., Gruppo, R., Sidonio, R., Ahuja, S., Carpenter, S., Pipe, S., Shapiro, A.

Volltext

Patient/Caregiver-reported recombinant factor VIIa (rFVIIa) dosing: home treatment of acute bleeds in the Dosing Observational Study in Hemophilia (DOSE) von YOUNG, G., SHAPIRO, A. D., WALSH, C. E., GRUPPO, R. A., GUT, R. Z., COOPER, D. L.

Volltext

Assessment of individual dose utilization vs. physician prescribing recommendations for recombinant activated factor VII (rFVIIa) in paediatric and adult patients with congenital h... von Gruppo, R. A., Kessler, C. M., Neufeld, E. J., Cooper, D. L.

Volltext

Radionuclide synovectomy in patients with bleeding disorders: a review of malignancy and myeloproliferative neoplasms from the ATHNdataset von Lim, M. Y., Cheng, D., Aschman, D., Dunn, A., Ahuja, S, Carpenter, SL, Davis, JA, French, J, Gruppo, R, Knoll, C, McGuinn, C, Pipe, SW, Sanders, J, Shapiro, A, Sidonio, R, Soni, A, Stein, DT, Tarantino, MD, Paroskie, A, Young, G

Volltext

BDDrFVIII (Moroctocog alfa [AF-CC]) for surgical haemostasis in patients with haemophilia A: results of a pivotal study von WINDYGA, J., RUSEN, L., GRUPPO, R., O'BRIEN, A. C., KELLY, P., ROTH, D. A, ARKIN, S.

Volltext

Comparative effectiveness of full-length and B-domain deleted factor VIII for prophylaxis - a meta-analysis von Gruppo, R. A., Brown, D., Wilkes, M. M., Navickis, R. J.

Volltext

Laboratory variability in the diagnosis of type 2 VWD variants von DiGiandomenico, Stefanie, Christopherson, Pamela A., Haberichter, Sandra L., Abshire, Thomas C., Montgomery, Robert R., Flood, Veronica H., Valentino, L., Abshire, T., Dunn, A., Bennett, C., Lusher, J., Rajpurkar, M., Hoots, W. K., Brown, D., Shapiro, A., Paola, J. Di, Lentz, S., Gill, J., Leissinger, C., Ragni, M., Hord, J., Manco‐Johnson, M., Ma, A., Boggio, L., Sharathkumar, A., Gruppo, R., Kerlin, B., Journeycake, J., Kulkarni, R., Mahoney, D, Mathias, L., Bedros, A., Diamond, C., Neff, A., Paroskie, A., DiMichele, D., Giardina, P., Cohen, A., Paidas, M., Werner, E., Matsunaga, A., Singer, T., Tarantino, M., Roberts, J., Shafer, F., Konkle, B., Cuker, A., Kouides, P., Stein, D., Manco‐Johnson, M., Dunn, A., Bennett, C., Journeycake, J., Lusher, J., Rajpurkar, M., Shapiro, A., Lentz, S., Lillicrap, D., James, P., Leissinger, C., Roberts, J., Ragni, M.

Volltext

Clinical evaluation of glycoPEGylated recombinant FVIII: Efficacy and safety in severe haemophilia A von Giangrande, Paul, Andreeva, Tatiana, Chowdary, Pratima, Ehrenforth, Silke, Hanabusa, Hideji, Leebeek, Frank W. G., Lentz, Steven R., Nemes, Laszlo, Poulsen, Lone Hvitfeldt, Santagostino, Elena, You, Chur Woo, Ong Clausen, Wan Hui, Jönsson, Peter G., Oldenburg, Johannes

Volltext

A Multicenter Study of Recombinant Factor VIII (Recombinate): Safety, Efficacy, and Inhibitor Risk in Previously Untreated Patients With Hemophilia A von Bray, G.L., Gomperts, E.D., Courier, S., Gruppo, R., Gordon, E.M., Manco-Johnson, M., Shapiro, A., Scheibel, E., III, G. White, Lee, M.

Volltext

Crucial role for the VWF A1 domain in binding to type IV collagen von Flood, Veronica H., Schlauderaff, Abraham C., Haberichter, Sandra L., Slobodianuk, Tricia L., Jacobi, Paula M., Bellissimo, Daniel B., Christopherson, Pamela A., Friedman, Kenneth D., Gill, Joan Cox, Hoffmann, Raymond G., Montgomery, Robert R.

Volltext

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura von Levy, Gallia G., Nichols, William C., Lian, Eric C., Foroud, Tatiana, McClintick, Jeanette N., McGee, Beth M., Yang, Angela Y., Siemieniak, David R., Stark, Kenneth R., Gruppo, Ralph, Sarode, Ravindra, Shurin, Susan B., Chandrasekaran, Visalam, Stabler, Sally P., Sabio, Hernan, Bouhassira, Eric E., Upshaw, Jefferson D., Ginsburg, David, Tsai, Han-Mou

Volltext

Increased breakthrough bleeding during prophylaxis with B-domain deleted factor VIII - a robust meta-analytic finding von Gruppo, R. A., Brown, D., Wilkes, M. M., Navickis, R. J.

Volltext

Meta-analytic evidence of increased breakthrough bleeding during prophylaxis with B-domain deleted factor VIII von Gruppo, R. A., Brown, D., Wilkes, M. M., Navickis, R. J.

Volltext

Break‐through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A von COLLINS, P. W., BLANCHETTE, V. S., FISCHER, K., BJÖRKMAN, S., OH, M., FRITSCH, S., SCHROTH, P., SPOTTS, G., ASTERMARK, J., EWENSTEIN, B.

Volltext

PROTECT VIII Kids: BAY 94‐9027 (PEGylated Recombinant Factor VIII) safety and efficacy in previously treated children with severe haemophilia A von Santagostino, Elena, Kenet, Gili, Fischer, Kathelijn, Biss, Tina, Ahuja, Sanjay, Steele, MacGregor, Martínez, M., Male, C., van Geet, C., Mondelaers, V., Kaleva, V., Stoyanova‐Deleva, A., Bobev, D., Blanchette, V., Zanon, E., Gagliano, F., Rageliene, L., Peters, M., Mlynarski, W., Badowska, W., Serban, M., Rusen, L., Uscatescu, V., Will, A., Payne, J., Tunstall, O., Kerlin, B., Gruppo, R., Eyster, M. E., Ducore, J., Schwartz, J.

Volltext